Rallybio RLYB Income Statement (2020-2026)

NASDAQ RLYB
$16.60 -0.40 (-2.35%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
4.02M3.19M4.02M4.02M4.01M4.73M4.72M4.72M4.73M4.73M4.73M5.19M5.19M5.19M5.20M5.21M5.24M5.28M5.29M5.31M
Revenue & cost
Revenue (Quarter)
0.30M0.30M0.04M0.21M0.21M0.21M0.22M0.21M
Operating items
Research & Development (Quarter)
4.96M6.09M7.65M10.14M12.11M-26.80M11.20M13.13M13.29M15.92M12.94M12.95M8.24M7.38M5.72M6.07M4.14M3.65M2.87M0.76M
Selling, General & Administrative (Quarter)
5.02M6.22M6.67M7.48M6.75M6.30M7.17M6.95M6.08M5.19M6.85M4.39M4.12M4.26M4.16M4.20M2.99M2.98M6.07M4.89M
Other Operating Expenses (Quarter)
37.59M
Operating Expenses (Quarter)
9.98M12.31M14.32M17.61M18.86M17.09M18.37M20.08M19.36M21.11M19.79M17.33M12.37M11.65M9.88M10.27M7.14M6.63M8.95M5.65M
Operating Income (Quarter)
-9.98M-12.31M-14.32M-17.61M-18.86M-17.09M-18.37M-20.08M-19.36M-21.11M-19.79M-17.04M-12.07M-11.61M-9.67M-10.06M-6.92M-6.41M-8.73M-5.65M
EBIT (Quarter)
-9.98M-12.31M-14.32M-17.61M-18.86M-17.09M-18.37M-20.08M-19.36M-21.11M-19.79M-17.04M-12.07M-11.61M-9.67M-10.06M-6.92M-6.41M-8.73M-5.65M
Non-operating items
Non Operating Investment Income (Quarter)
-0.12M-0.25M-0.06M0.22M0.15M-0.21M0.06M0.22M-0.09M0.24M-0.10M-0.02M-0.03M0.01M-0.01M-0.02M-0.00M
Interest & Investment Income (Quarter)
0.01M0.01M0.10M0.27M0.53M1.07M1.55M1.61M1.54M1.45M1.28M1.14M0.99M0.81M0.64M0.52M0.46M0.56M0.20M0.22M
Other Non Operating Income (Quarter)
0.10M0.11M0.11M0.10M0.10M0.03M0.07M0.06M0.09M0.04M0.17M0.14M0.25M0.18M0.17M0.12M22.48M0.25M0.42M
Non Operating Income (Quarter)
0.12M0.12M0.21M0.37M0.62M1.10M1.62M1.67M1.64M1.48M1.44M1.29M1.24M0.99M0.82M0.64M22.94M0.56M0.46M50.64M
Net income details
EBT (Quarter)
-9.86M-12.19M-14.11M-17.25M-18.24M-15.99M-16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M-5.85M-8.28M44.99M
Tax Provisions (Quarter)
1.32M
Profit After Tax (Quarter)
-10.20M-12.41M-14.62M-17.58M-18.43M-15.77M-17.16M-18.63M-18.37M-20.28M-19.03M-16.24M-11.47M-11.20M-9.46M-9.73M16.02M-5.87M-8.29M43.66M
Income from Continuing Operations (Quarter)
-9.86M-12.19M-14.11M-17.25M-18.24M-15.99M-16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M-5.85M-8.28M43.66M
Consolidated Net Income (Quarter)
-9.86M-12.19M-14.11M-17.25M-18.24M-15.99M-16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M-5.85M-8.28M43.66M
Income towards Parent Company (Quarter)
-9.86M-12.19M-14.11M-17.25M-18.24M-15.99M-16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M-5.85M-8.28M43.66M
Net Income towards Common Stockholders (Quarter)
-9.86M-12.19M-14.11M-17.25M-18.24M-15.99M-16.75M-18.41M-17.73M-19.63M-18.34M-15.75M-10.83M-10.61M-8.85M-9.42M16.02M-5.85M-8.28M43.66M
Additional items
EPS (Basic) (Quarter)
-2.87-3.82-3.72-4.51-4.74-4.02-3.33-3.65-3.50-3.88-3.60-2.86-1.94-1.95-1.58-1.682.84-1.04-1.467.66
EPS (Diluted) (Quarter)
-2.87-3.82-3.72-4.51-4.74-4.02-3.33-3.65-3.50-3.88-3.60-2.86-1.94-1.95-1.58-1.682.84-1.04-1.467.53
Shares Outstanding (Quarter)
3.44M3.19M3.79M3.82M3.85M3.98M5.03M5.05M5.07M5.06M5.10M5.52M5.57M5.44M5.60M5.61M5.63M5.63M5.69M5.70M
Shares Outstanding (Diluted) (Quarter)
3.44M3.19M3.79M3.82M3.85M3.98M5.03M5.05M5.07M5.06M5.10M5.52M5.57M5.44M5.60M5.61M5.63M5.63M5.69M5.80M
EBITDA (Quarter)
-9.98M-12.31M-14.32M-17.61M-18.86M-17.09M-18.37M-20.08M-19.36M-21.11M-19.79M-17.04M-12.07M-11.61M-9.67M-10.06M-6.92M-6.41M-8.73M-5.65M
Interest Expenses (Quarter)
0.03M-0.06M0.23M0.67M4.36M0.20M0.09M0.28M0.22M78.28M0.08M0.07M0.00M98.00M0.01M0.01M0.05M0.09M0.75M2.35M
Tax Rate (Quarter)
2.94